EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Designing Small Molecule PI3Kγ Inhibitors: A Review of Structure-Based Methods and Computational Approaches

Xiaoming Yin, Jiaying Wang, Minghao Ge, Xue Feng, Guogang Zhang iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Xiaoming Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hebei University of Science & Technology, Shijiazhuang 050018, People's Republic of China. Hauptthemen laut MEDLINE: Class Ib Phosphatidylinositol 3-Kinase, Drug Design, Phosphoinositide-3 Kinase Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Gefördert von: Hebei Research Center of Pharmaceutical and Chemical Engineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The PI3K/AKT/mTOR pathway plays critical roles in a wide array of biological processes. Phosphatidylinositol 3-kinase gamma (PI3Kγ), a class IB PI3K family member, represents a potential therapeutic opportunity for the treatment of cancer, inflammation, and autoimmunity. In this Perspective, we provide a comprehensive overview of the structure, biological function, and regulation of PI3Kγ. We also focus on the development of PI3Kγ inhibitors over the past decade and emphasize their binding modes, structure-activity relationships, and pharmacological activities. The application of computational technologies and artificial intelligence in the discovery of novel PI3Kγ inhibitors is also introduced. This review aims to provide a timely and updated overview on the strategies for targeting PI3Kγ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Class Ib Phosphatidylinositol 3-KinaseDrug DesignPhosphoinositide-3 Kinase InhibitorsHumansStructure-Activity RelationshipSmall Molecule LibrariesAnimalsProtein Kinase InhibitorsMolecular Structure

Substanzen

Class Ib Phosphatidylinositol 3-KinasePhosphoinositide-3 Kinase InhibitorsSmall Molecule LibrariesPIK3CG protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Hebei University of Science & Technology, Shijiazhuang 050018, People's Republic of China.
  • Hebei Research Center of Pharmaceutical and Chemical Engineering, Shijiazhuang 050018, People's Republic of China.

ORCID-Profile: Guogang Zhang

Förderung

  • Hebei Research Center of Pharmaceutical and Chemical Engineering

Zitieren

APA

Yin, X., Wang, J., Ge, M., Feng, X., & Zhang, G. (2024). Designing Small Molecule PI3Kγ Inhibitors: A Review of Structure-Based Methods and Computational Approaches. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00347

Vancouver

Yin X, Wang J, Ge M, Feng X, Zhang G. Designing Small Molecule PI3Kγ Inhibitors: A Review of Structure-Based Methods and Computational Approaches. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00347

BibTeX
@article{Yin2024,
  author = {Yin, Xiaoming and Wang, Jiaying and Ge, Minghao and Feng, Xue and Zhang, Guogang},
  title = {Designing Small Molecule PI3Kγ Inhibitors: A Review of Structure-Based Methods and Computational Approaches},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00347}
}
Kostenlos starten →